Bio-Techne soars on $11.3 billion buyout deal from Merck

Merck KGaA

25/06/2026 14:39

Updates
** Shares of life sciences firm Bio-Techne TECH.O rise 19.2% to $70.20
** Merck KGaA MRCG.DE says it will buy Bio-Techne for $73 per share in cash, representing a total enterprise value of about $11.3 billion
** The offer price represents a 24% premium to TECH's last close 
** Merck says the acquisition will be funded through a combination of existing cash and proceeds from new debt 
** "We're not surprised by the strategic interest and consider the combination a solid fit," RBC Capital Markets says
** Including session's move, TECH up 19.4% YTD

 (Reporting by Christy Santhosh and Kunal Das)
 ((Christy.Santhosh@thomsonreuters.com))